Sivraj Muralikrishnan

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.

A. Zelenetz, B. Cheson, A. Schuh, 2019, Blood advances.

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report

K. Shirai, Sivraj Muralikrishnan, Paula K. Rauschkolb, 2020, Case Reports in Oncology.

Breast cancer patients with brain metastasis undergoing GKRS

C. Hatzis, James B. Yu, M. Abu-Khalaf, 2018, Breast Cancer.

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

B. Cheson, A. Schuh, C. Nabhan, 2019, Clinical Cancer Research.

Chemotherapy for Elderly Ovarian Cancer Patients

C. Hatzis, P. Schwartz, A. Santin, 2016, Gynecology & obstetrics.

Comparison of Oncologist and Model Estimates of Risk for Hospitalization During Systemic Therapy for Advanced Cancer

A. Tosteson, G. Brooks, Sivraj Muralikrishnan, 2022, JCO oncology practice.

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.

A. Zelenetz, B. Cheson, A. Schuh, 2019, Blood advances.